Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
The evidence depends on the technology, but it may include laboratory notebooks, study protocols, genetic or sequence data, assay results, microscopy, bioinformatics outputs, cell-culture records, validation studies, batch or production records, specifications, quality-control data, and research communications. An expert may use those records to evaluate how the underlying methods and analyses led to the reported results and whether controls, data interpretation, or development history are material to the dispute.
Plant biotechnology becomes relevant when the disputed science involves using biological or genetic techniques to develop, characterize, or modify plants and plant traits. Depending on the matter, the evidence may involve genomics, genetic engineering, genome editing, molecular markers, breeding data, trait characterization, or experimental results. USDA's National Institute of Food and Agriculture describes plant biotechnology as encompassing techniques such as genetics and genomics, marker-assisted selection, transgenic crops, genome editing, bioinformatics, and synthetic biology. Plant Biotechnology is a specialized application of broader biotechnology, and plant-focused disputes may call for an expert with more specific experience in plant genetics, breeding, crop biotechnology, or related plant-science methods.
Environmental biotechnology applies biological systems or microorganisms to environmental applications. A dispute might involve microbial processes, engineered organisms, biodegradation, bioremediation, environmental release, or performance of a biological treatment process. EPA describes bioremediation as the use of microorganisms to degrade contaminants and separately regulates certain biotechnology microorganisms under the Toxic Substances Control Act. EPA also identifies genetically or metabolically engineered microorganisms for bioremediation as an example of biotechnology products. When the principal question concerns environmental impact or remediation rather than the biotechnology itself, Environmental Science or Environmental Engineering may be the more appropriate retained expertise.
Biochemistry, +4
Biotechnology
Agriculture, +4
Agriculture
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
Bioinformatics can become relevant when computational analysis is used to interpret sequence, genomic, expression, or other biological data. An expert may need to understand the input data, analytical workflow, software or pipeline, reference datasets, and how computational outputs were used to reach a biological conclusion. Synthetic biology represents another biotechnology application involving the design or modification of biological systems. The National Academies describes biotechnology broadly as applying biological components or processes for human purposes and synthetic biology as a narrower set of approaches within biotechnology.
A broader Biotechnology Expert Witness may be appropriate when the disputed question concerns development methods, characterization, laboratory data, production processes, or underlying biotechnology. A more specialized expert may be necessary when the central issue involves clinical use, cellular mechanisms, therapeutic safety or efficacy, or patient-specific medical causation. FDA regulates cellular and gene therapy products through specialized programs within CBER, including certain autologous, allogeneic, and stem-cell-based products. The applicable regulatory pathway varies with the particular cell or tissue product and its characteristics and intended use.
Biotechnology, +4
Biotechnology
Biotechnology, +4
Biotechnology
